Top Markets
#1 Black Phoenix Black Phoenix +342.75%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +61.75%
#4 Gold Park Gold Park +55.15%
#5 BasedHype BasedHype +29.66%
#6 Acurast Acurast +25.65%
#7 Cryptopia Cryptopia +22.04%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.03%
#9 Avantis Avantis +18.81%
#10 MYX Finance MYX Finance +14.22%
Coin of the day
Black Phoenix Black Phoenix
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Rankning i aktier #40877
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Aktiekurs
$0.013
Senast synkroniserad: 2026-08-12
Marknadsvärde
$68.05K
Förändring (1 dag)
0.00%
Förändring (1 år)
-66.67%
Land
US
Handel Vincerx Pharma, Inc. (VINC)

Kategori

Healthcare
Aktiekurshistorik för Vincerx Pharma, Inc. (VINC)
Högsta slutkurs: $0.01 den 2026-08-01

Lägsta slutkurs: $195.93 den 2020-05-01
Aktiekurshistorik för Vincerx Pharma, Inc. från 2020 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 86.64%
2025 -99.71%
2024 -70.59%
2023 -10.91%
2022 -91.75%
2021 -41.58%
2020 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $523.97 32.34%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $867.22 34.12%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE